医学
宫颈癌
人口
肺癌
肿瘤科
癌症
内科学
环境卫生
作者
Krishnansu S. Tewari,Bradley J. Monk,Ignace Vergote,Austin Miller,Andréia Cristina de Melo,Hee‐Seung Kim,Yong Man Kim,Alla Lisyanskaya,Vanessa Samouëlian,Domenica Lorusso,Fernanda Damian,Chih‐Long Chang,Evgeniy A. Gotovkin,Shunji Takahashi,Daniella Ramone,Joanna Pikiel,Beata Maćkowiak-Matejczyk,Eva Maria Guerra Alía,Nicoletta Colombo,Yulia Makarova
标识
DOI：10.1056/nejmoa2112187
摘要
Patients with recurrent cervical cancer have a poor prognosis. Cemiplimab, the fully human programmed cell death 1 (PD-1)–blocking antibody approved to treat lung and skin cancers, has been shown to have preliminary clinical activity in this population.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
犹豫的大碗
贪玩的秋柔
你嵙这个期刊没买
小米
风吹麦田
大力的灵雁
无极微光
damapd
干净的琦
仰望喀纳斯的星空
啊伟
伊比利亚的微风
Criminology34
yuxing
GingerF
愔愔
埃塞克斯
Whim
Twonej
皖公网安备34019202002308
